Exploiting phages and toxin-antitoxin systems for synthetic biology, bacterial pathogen host range analysis, phage therapy and novel antibiotics.

利用噬菌体和毒素-抗毒素系统进行合成生物学、细菌病原体宿主范围分析、噬菌体治疗和新型抗生素。

• 批准号: 1800142
• 金额: --
• 依托单位: University of Cambridge
• 依托单位国家: 英国
• 项目类别: Studentship
• 财政年份: 2016
• 资助国家: 英国
• 起止时间: 2016 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=studentship-1800142
• 关键词: Exploiting; phages; toxin; antitoxin; systems

Bacteriophages (phages) are bacterial viruses that are the most abundant biological entities on Earth. As bacterial predators they outnumber their hosts by 10 to 1 yet bacteria are still around because they have evolved clever strategies to avoid the potentially lethal impacts of phage infection. These include phage receptor alterations, restriction and modification (R&M), CRISPR-Cas mechanisms and generic abortive infection (Abi) systems, some with toxin-antitoxin (TA) functionality. Type III TA systems can have Abi capacity and these operate via an RNA antitoxin that suppresses the suicidal lethality of a proteinaceous endoribonuclease toxin in the corresponding bacterial hosts. In this project the student will investigate multiple aspects of phage biology. He/she will use synthetic biology to genetically engineer phages with restrictive host ranges to evolve them into promiscuous viruses that may be able to infect diverse bacterial pathogens, thereby increasing their potential utility in the development of lethal phage therapy models. Further, the student will investigate how some phages are aborted on bacterial infection by endogenous Type III TA systems that are phage-activated - and yet lead to the termination of viral replication (a system that may have evolved in bacteria originally to diminish propagation of their phage parasites). The mechanism of viral escape from the Type III systems will be investigated. Finally, the student will screen diverse small molecule libraries to search for chemical entities that can activate endogenous lethal TA systems in bacterial pathogens as a new route to the identification of novel chemotherapeutic antimicrobials.

噬菌体（噬菌体）是细菌病毒，是地球上最丰富的生物实体。作为细菌捕食者，它们的数量比宿主多 10 比 1，但细菌仍然存在，因为它们进化出了聪明的策略来避免噬菌体感染的潜在致命影响。其中包括噬菌体受体改变、限制和修饰 (R&M)、CRISPR-Cas 机制和通用流产感染 (Abi) 系统，其中一些系统具有毒素-抗毒素 (TA) 功能。 III型TA系统可以具有Abi能力，并且这些系统通过RNA抗毒素起作用，该抗毒素抑制相应细菌宿主中蛋白质核糖核酸内切酶毒素的自杀致死性。在这个项目中，学生将研究噬菌体生物学的多个方面。他/她将利用合成生物学对具有限制性宿主范围的噬菌体进行基因改造，将其进化为能够感染多种细菌病原体的混杂病毒，从而增加其在开发致命噬菌体治疗模型中的潜在效用。此外，学生还将研究一些噬菌体如何在细菌感染时被噬菌体激活的内源性 III 型 TA 系统中止，并导致病毒复制终止（该系统最初可能在细菌中进化，以减少噬菌体寄生虫的繁殖）。将研究病毒从 III 型系统逃逸的机制。最后，学生将筛选不同的小分子库，以寻找可以激活细菌病原体中内源性致死 TA 系统的化学实体，作为识别新型化疗抗菌药物的新途径。